Nuclear Medicine Market By Type (Diagnostic and Therapeutic), Application (Neurology, Cardiology), End-user (Hospitals & Clinics, Diagnostic Centers), & Region for 2024-2031
Published on: 2024-08-06 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Nuclear Medicine Market By Type (Diagnostic and Therapeutic), Application (Neurology, Cardiology), End-user (Hospitals & Clinics, Diagnostic Centers), & Region for 2024-2031
Nuclear Medicine Market Valuation – 2024-2031
The growing prevalence of cancer and cardiac diseases and the increasing demand for image-guided procedures and diagnostics are propelling the adoption of nuclear medicine. Also, rising partnerships and collaborations in the research sector of the radioisotopes market are a prominent factor leading to market size surpassing USD 6.88 Billion in 2024 to reach a valuation of around USD 12.99 USD Billion by 2031.
In addition to this, growing technological advancements that enable the use of radiopharmaceuticals to diagnose and treat cancerous tumors are contributing to market growth. The market players focus on various strategies, such as new product launches and acquisitions, enabling the market to grow at a CAGR of 9.30% from 2024 to 2031.
Nuclear Medicine MarketDefinition/ Overview
Nuclear medicine is a medical specialty that utilizes radioactive substances, known as radiopharmaceuticals, to diagnose and treat diseases. These radiopharmaceuticals emit gamma rays, which are detected by specialized imaging devices such as gamma cameras or PET scanners. Nuclear medicine techniques provide valuable information about the structure and function of organs and tissues within the body, aiding in the diagnosis, staging, and monitoring of various medical conditions.
Nuclear medicine is used to diagnose various conditions like cancer, heart disease, bone disorders, and neurological problems. Therapies using radioisotopes can target and destroy diseased cells, particularly in thyroid disorders and some cancers. Nuclear medicine also encompasses therapeutic applications, such as targeted radionuclide therapy (TRT). In TRT, radioactive substances are administered to patients to selectively deliver radiation to specific disease sites, such as tumors, while sparing healthy tissues.
Advances in molecular imaging and radiopharmaceutical development are driving the emergence of precision nuclear medicine techniques. These techniques enable personalized diagnosis and treatment strategies tailored to individual patients’ molecular profiles, leading to improved clinical outcomes and reduced side effects.
What's inside a
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
How will the Increase Prevalence of Cancer Drives the Market of Nuclear Medicine?
The rising incidence of cancer is the major factor propelling the market of nuclear medicine. Nuclear medicine imaging provides valuable information about tumor biology, heterogeneity, and receptor expression patterns. This data enables oncologists to tailor treatment strategies based on individual patient characteristics, leading to more personalized and effective cancer therapies.
Increasing cases of cardiovascular disease boosts the market growth of nuclear medicine. Nuclear medicine techniques are indispensable for the evaluation of ischemic heart disease (IHD) and the assessment of myocardial viability. Stress myocardial perfusion imaging with SPECT or PET, combined with pharmacological or exercise stress testing, helps identify areas of myocardial ischemia and determine the extent of viable myocardium in patients with CAD. this enables the market growth.
The shift towards personalized medicine and precision oncology drives the adoption of nuclear medicine techniques for molecular imaging, molecular profiling, and targeted therapies. Nuclear imaging technologies enable the visualization of molecular processes within the body, facilitating the development of personalized
Furthermore, Theranostics, combining diagnostic imaging and therapeutic interventions using the same radiopharmaceutical, represents a promising approach in nuclear medicine. Theranostic techniques enable personalized treatment planning, real-time monitoring of treatment response, and optimization of therapeutic outcomes, driving market expansion.
Will High Costs of Nuclear Medicine Restrain Its Application?
Nuclear medicine equipment, such as PET/CT scanners and cyclotrons, is expensive to purchase, install, and maintain. Additionally, the cost of radiopharmaceuticals used in nuclear medicine procedures can be substantial. These high upfront and operational costs may limit the accessibility of nuclear medicine services, particularly in resource-constrained healthcare settings.
Nuclear medicine procedures involve the use of radioactive materials and ionizing radiation, subjecting healthcare facilities to stringent regulatory requirements and safety standards. Compliance with regulatory guidelines, licensing procedures, radiation safety protocols, and quality assurance measures adds complexity and administrative burden to nuclear medicine practice, potentially impeding market growth.
In addition to this, despite the low radiation doses associated with nuclear medicine procedures, concerns about radiation exposure persist among patients and healthcare providers. Misconceptions about radiation risks, fear of radiation-induced adverse effects, and reluctance to undergo nuclear imaging or therapy may deter patients from seeking nuclear medicine services, hindering market demand.
Furthermore, Reimbursement policies and insurance coverage for nuclear medicine procedures vary across regions and healthcare systems. Inadequate reimbursement rates, coverage restrictions, and reimbursement delays may deter healthcare providers from offering nuclear medicine services or investing in nuclear medicine technology, limiting market expansion.
Category-Wise Acumens
How Will the Rise in the Adoption of Diagnostic Nuclear Medicine Drive the Market?
Diagnostic nuclear medicine is anticipated to hold a major share in the nuclear medicine market. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions drives the demand for accurate and early diagnostic tools. Diagnostic nuclear medicine plays a crucial role in addressing this need, contributing to its dominance in the nuclear medicine market.
Diagnostic nuclear medicine techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and planar scintigraphy have diverse clinical applications across multiple medical specialties. These imaging modalities are used for the diagnosis, staging, and monitoring of various diseases, including cancer, cardiovascular disorders, neurological conditions, and endocrine diseases.
Diagnostic nuclear medicine plays a crucial role in the early detection of diseases, allowing for prompt intervention and improved treatment outcomes. By visualizing metabolic and physiological changes within the body, nuclear imaging techniques enable the detection of diseases at early stages when treatment options may be more effective.
Also, ongoing advancements in nuclear imaging technology, including improved imaging resolution, sensitivity, and hybrid imaging systems (e.g., PET/CT, SPECT/CT), enhance the diagnostic capabilities of nuclear medicine. These technological innovations make diagnostic nuclear medicine more accurate, reliable, and accessible to healthcare providers and patients.
Which Factors Enhance the Use of Nuclear Medicine in Hospitals?
Hospitals are major healthcare facilities that provide a wide range of diagnostic services to patients. With the rising prevalence of chronic diseases and the growing need for accurate and early disease detection, hospitals are increasingly incorporating nuclear medicine imaging techniques such as PET, SPECT, and hybrid imaging (PET/CT, SPECT/CT) into their diagnostic armamentarium. The expansion of diagnostic services within hospitals drives the demand for nuclear medicine equipment, radiopharmaceuticals, and related technologies, fueling market growth.
Rising collaboration with academic institutions, research organizations, and industry stakeholders to advance nuclear medicine research, technology development, and clinical practice contributes to the growth of the hospital segment.
Increasing demand for imaging and therapy services leads hospitals to develop their infrastructure. This includes the installation of state-of-the-art imaging equipment, the establishment of dedicated nuclear medicine departments or centers, and the recruitment of trained personnel, including nuclear medicine technologists, radiopharmacists, and nuclear medicine physicians. The expansion of nuclear medicine infrastructure within hospitals supports market growth and facilitates the delivery of high-quality patient care.
Gain Access to Nuclear Medicine Market Report Methodology
Country/Region-wise Acumens
Will Growing R&D Expenditure in North America Mature Nuclear Medicine Market?
Increased R&D investment fosters innovation in nuclear medicine technology, leading to the development of advanced imaging systems, radiopharmaceuticals, and therapeutic techniques. These technological advancements enhance the accuracy, sensitivity, and specificity of nuclear medicine procedures, expanding their clinical applications and driving market growth.
Also, North America offers widespread availability of nuclear medicine services across various healthcare settings, including hospitals, diagnostic imaging centers, and specialized clinics. The region’s extensive network of healthcare providers and nuclear medicine facilities ensures accessibility and affordability of nuclear medicine procedures, supporting market dominance.
Furthermore, North America has a well-established regulatory framework governing the approval and commercialization of nuclear medicine products. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) ensure safety, efficacy, and quality standards, fostering investor confidence and market growth. The region’s regulatory environment facilitates the introduction of new nuclear medicine technologies, contributing to market dominance.
Will an Increase in Disposable Incomes across the Asia Pacific Drive the Nuclear Medicine Market?
Increasing disposable incomes across the Asia Pacific region enable greater access to healthcare services, including advanced imaging diagnostics such as nuclear medicine. As more individuals in the region can afford healthcare expenditures, there is a growing awareness of the importance of imaging diagnostics in disease diagnosis and management.
Asia Pacific region advances economically and technologically, there is a corresponding uptake of advanced imaging technologies, including nuclear medicine. Technological advancements in nuclear imaging systems, radiopharmaceuticals, and data analysis tools enhance the accuracy, efficiency, and safety of nuclear medicine procedures, driving market growth.
Competitive Landscape
The nuclear medicine market is a competitive landscape with established players battling for dominance. Niche players are also emerging, focusing on specific radiopharmaceuticals or innovative technologies like theranostics. This mix of established giants, specialized radiopharmaceutical companies, and rising niche players keeps the market dynamic, pushing for constant advancements in nuclear medicine technology. Some of the prominent players operating in the nuclear medicine market include
- Lantheus Medical Imaging, Inc.
- Cardinal Health
- Norgine B.V.
- Nordion Inc.
- Bayer AG
- Curium
- Advanced Accelerator Applications
- Bracco Diagnostic Inc.
- Jubilant Pharmova Limited
- GE Healthcare (General Electric Company)
Latest Developments
- In February 2023, Telix Pharmaceuticals Limited has recently announced the successful completion of its collaborative research project with Heidelberg University Hospital (UKHD) in February 2021. The purpose of this project was to develop and validate a generator-based theranostic compound for urologic oncology. The compound is aimed at targeting PSMA and utilizes the beta-emitting isotope rhenium-188 (188Re).
- In March 2021, Global Medical Solutions, Ltd. (GMS) and BWXT Medical Ltd. entered into a joint venture (V) to manufacture and distribute radioisotopes in the Asia-Pacific.
- In March 2021, Bracco Diagnostics Inc. partnered with CardioNavix, LLC to expand patient access to cardiac PET imaging. The Bracco Mobile Isotope Service program will allow more patient care sites to offer cardiac PET imaging.
- In August 2021, GE Healthcare and NorthStar Medical Radioisotopes, LLC entered into an exclusive agreement for manufacturing and distributing iodine-123 (1-123) capsules in the US.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
Study Period | 2021-2031 |
Growth Rate | CAGR of ~9.30% from 2024 to 2031 |
Base Year for Valuation | 2024 |
Historical Period | 2021-2023 |
Forecast Period | 2024-2031 |
Quantitative Units | Value in USD Billion |
Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
Segments Covered |
|
Regions Covered |
|
Key Players | Lantheus Medical Imaging, Inc., Cardinal Health, Norgine B.V., Nordion Inc., Bayer AG, Curium, Advanced Accelerator Applications, Bracco Diagnostic Inc., Jubilant Pharmova Limited, GE Healthcare (General Electric Company) |
Customization | Report customization along with purchase available upon request |
Nuclear Medicine Market, By Category
Type
- Diagnostic Nuclear Medicine
- PET Radiopharmaceuticals
- SPECT Radiopharmaceuticals
- Therapeutic Nuclear Medicine
Application
- Neurology
- Cardiology
- Oncology
End-Users
- Hospitals & Clinics
- Diagnostic Centers
Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.